Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

929 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Induction Therapy With a Combination of Weekly Adalimumab Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis in Patients With Ulcerative Colitis and Failure of Conventional Agents, Biologics and Janus Kinase Inhibitor.
Tanida S, Ozeki K, Katano T, Tanaka M, Shimura T, Kubota E, Kataoka H, Takahama T, Sasoh S, Kubota Y, Ban T, Ando T, Nakamura M, Joh T. Tanida S, et al. Among authors: joh t. J Clin Med Res. 2023 Mar;15(3):181-186. doi: 10.14740/jocmr4887. Epub 2023 Mar 28. J Clin Med Res. 2023. PMID: 37035853 Free PMC article.
A complicated case of tacrolimus-induced rapid remission after cesarean section in the early third trimester for refractory severe ulcerative colitis flaring in the initial period of gestation.
Mizushima T, Tanida S, Mizoshita T, Hirata Y, Murakami K, Shimura T, Kataoka H, Kamiya T, Joh T. Mizushima T, et al. Among authors: joh t. Case Rep Gastroenterol. 2011 Apr 12;5(1):144-51. doi: 10.1159/000326938. Case Rep Gastroenterol. 2011. PMID: 21552436 Free PMC article.
Combination therapy with adalimumab plus intensive granulocyte and monocyte adsorptive apheresis induced clinical remission in a Crohn's disease patient with the loss of response to scheduled adalimumab maintenance therapy: a case report.
Ozeki K, Tanida S, Mizushima T, Mizoshita T, Tsukamoto H, Hirata Y, Murakami K, Shimura T, Kataoka H, Kamiya T, Joh T. Ozeki K, et al. Among authors: joh t. Intern Med. 2012;51(6):595-9. doi: 10.2169/internalmedicine.51.6801. Epub 2012 Mar 15. Intern Med. 2012. PMID: 22449667 Free article.
929 results